Caitlyn Fastenau, PhD
banner
caitlynfastenau.bsky.social
Caitlyn Fastenau, PhD
@caitlynfastenau.bsky.social
PhD Integrated Biomedical Sciences | Clinical Trial Post-Doctoral Fellow @buckinstitute.org‬ | Alzheimer's Association A&D Journal Family Social Media Editor | 2024-2025 Alzheimer's Association ‪ISTAART Ambassador | Science Communicator
Reposted by Caitlyn Fastenau, PhD
Guest Editors:
🧪 Suvarna Alladi
🔬 Atanu Biswas
🧪 Sinjan Ghosh
🔬 Faheem Arshad

A&D Editor-in-Chief: Donna Wilcock @wilcocklab.bsky.social

Please contact the editors if there are concerns regarding publication fees.
November 7, 2025 at 7:04 PM
Interested in our other outstanding work on sialylation? Check out my other first-authored publications

🐁
pubmed.ncbi.nlm.nih.gov/36867284/

🧠
onlinelibrary.wiley.com/doi/full/10....
September 22, 2025 at 9:56 PM
This work was supported by my amazing PhD mentors @hoppzor.bsky.social and Dr. Kevin Bieniek, @uthealthsa.bsky.social and all co-authors👏

Check out our publication now! #ADRD
September 22, 2025 at 9:48 PM
Comparing across AD+CAA cases, there were less differences between sialylation levels in the space surrounding arterioles or the peri-vascular space. Further supporting CAA-driven increase in intra-vascular sialylation!
September 22, 2025 at 9:48 PM
Histologically, we determined AD+CAA brains have increased sialylation intravascularly compared to “pure AD” brains. Potentially suggesting the intersection of this PTM and vessel vulnerability🧠
September 22, 2025 at 9:48 PM
We focused on sialylation location in AD brains with Cerebral Amyloid Angiopathy (CAA)🩸. The increasing prevalence of ARIA events related to anti-amyloid therapies makes this work vitally important. We found significant differences in sialylation location between “pure AD” and AD+CAA!
September 22, 2025 at 9:48 PM